Pasithea Therapeutics Corp. (KTTA) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Pasithea Therapeutics Cor...

    NASDAQ: KTTA · Real-Time Price · USD
    0.79
    -0.01 (-0.75%)
    At close: Sep 05, 2025, 3:59 PM
    0.77
    -2.54%
    After-hours: Sep 05, 2025, 07:49 PM EDT

    Pasithea Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -0.25 -0.59 -1.24 -18.73
    PEG Ratio
    		 -0.79 -0.03 -0.00 -0.01
    PS Ratio
    		 n/a n/a 33.31 2.7K
    PB Ratio
    		 0.23 0.40 0.38 0.79
    P/FCF Ratio
    		 -0.00 -0.73 -0.97 -12.74
    P/OCF Ratio
    		 -0.00 -0.7 -1.11 -12.83
    OCF/S Ratio
    		 n/a n/a -29.93 -210.73
    Debt / Equity Ratio
    		 n/a 0.00 0.02 n/a
    Quick Ratio
    		 6.58 6.35 18.15 119.17
    Current Ratio
    		 6.58 6.34 18.15 119.17
    Asset Turnover
    		 n/a n/a 0.01 0.00
    Interest Coverage
    		 n/a n/a -145.26K -8.87K
    Return on Equity
    		 -0.94 -0.68 -0.31 -0.04
    Return on Assets
    		 -0.87 -0.61 -0.29 -0.04
    Return on Invested Capital
    		 -0.95 -0.68 -0.32 -0.09
    Dividend Yield
    		 104.17 n/a n/a n/a
    Payout Ratio
    		 -25.87 n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a 0.77 -0.15
    Net Profit Margin
    		 n/a n/a -26.83 -144.34
    Pretax Profit Margin
    		 n/a n/a -28.64 -144.3
    Operating Profit Margin
    		 n/a n/a -30.45 -299.26
    FCF Margin
    		 n/a n/a -34.32 -212.16
    EBITDA Margin
    		 n/a n/a -25.86 -299.17

    Add to Watchlist